NEOP just now on the AMEX and institutional interest is quickly building.
"NEOP" this cancer testing company is on the move. FDA approval seems to really like it thus far and has not found fault. Phase 3 trial should be ready this quarter and sounds like a shoe in. Take a minute and listen to this Bloomberg interview it should mean this biotech is going to move fast. NEOP on Bloomberg Radio: link below
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.